
Shares in Ambu AMBUb.CO fall 1.4%, pares losses after falling as much as 4.4%, after the Danish medical equipment maker reported a Q1 slight net profit and FCF before acquisitions miss
Ambu's Q1 net profit is a 3.6% miss "on slightly higher net financials and tax," says J.P. Morgan in a note
The broker also notes the Q1 FCF before acquisitions which was DKK 69 million ($9.63 million)compared to the consensus of DKK 130 million
The company previously raised its 2024/25 organic growth outlook, saying it is "mainly driven by better-than-expected revenue growth in Anaesthesia & Patient Monitoring, driven by price increases and solid volume growth"
JPM however says that pulmonology growth was better than expected but "benefitted from an order timing tailwind in Q1"
Up to the previous session's close, shares were up 34% YTD
($1 = 7.1614 Danish crowns)